表紙:局所ドラッグデリバリーの世界市場:製品別、地域別分析-予測(~2028年)
市場調査レポート
商品コード
1064096

局所ドラッグデリバリーの世界市場:製品別、地域別分析-予測(~2028年)

Topical Drug Delivery Market Forecasts to 2028 - Global Analysis By Product (Liquid Formulations, Solid Formulations, Devices (Transdermal Drug Delivery), Semi-Solid Formulations), and By Geography

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
局所ドラッグデリバリーの世界市場:製品別、地域別分析-予測(~2028年)
出版日: 2022年07月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の局所ドラッグデリバリーの市場規模は、2021年に1,012億9,000万米ドルとなり、2028年には1,781億5,000万米ドルに達し、予測期間中のCAGRは8.4%となる見込みです。

当レポートでは、世界の局所ドラッグデリバリー市場について調査分析し、促進要因、抑制要因、投与経路・製品・流通チャネル・使用施設・タイプ・地域別市場分析、企業プロファイルを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 市場機会
  • 脅威
  • 製品分析
  • 新興市場
  • COVID-19の影響

第4章 ポーターのファイブフォース分析

第5章 局所ドラッグデリバリーの世界市場:投与経路別

  • 膣ドラッグデリバリー
  • 直腸ドラッグデリバリー
  • 眼科用ドラッグデリバリー
  • 経鼻ドラッグデリバリー
  • 皮膚ドラッグデリバリー

第6章 局所ドラッグデリバリーの世界市場:製品別

  • 液体製剤
    • 懸濁液
    • 溶液
  • 固形製剤
    • 坐剤
    • 粉体
  • デバイス(経皮吸収型ドラッグデリバリー)
    • 経皮吸収型半固形剤
    • 経皮吸収型パッチ
    • 吸入器
  • 半固形製剤
    • ペースト
    • 軟膏
    • ローション
    • ジェル
    • クリーム

第7章 局所ドラッグデリバリーの世界市場:流通チャネル別

  • 小売
    • オフライン
    • オンライン
  • 直接入札

第8章 局所ドラッグデリバリーの世界市場:使用施設別

  • 病院・民間クリニック
  • 在宅ケアの設定
  • 火傷治療センター
  • その他の施設
    • 学術・研究機関
    • 診断センター

第9章 局所ドラッグデリバリーの世界市場:タイプ別

  • 硬質ブレース
  • ヒンジ付きブレース
  • 軟質・伸縮性ブレース

第10章 局所ドラッグデリバリーの世界市場:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東・アフリカ

第11章 主な発展

  • 契約、パートナーシップ、コラボレーション、ジョイントベンチャー
  • 買収と合併
  • 新製品の発売
  • 事業拡大
  • その他の主要戦略

第12章 企業プロファイル

  • Teligent Pharma
  • Almirall, S.A
  • Perrigo Pharma
  • Novartis AG
  • Bayer AG
  • Mylan
  • Merck & Co
  • LEO Pharma
  • Johnson & Johnson
  • Agile Therapeutics Inc.
  • Cipla Ltd
  • GlaxoSmithKline
  • Encore Dermatology, Inc.
  • Crescita Therapeutics Inc.
  • Taro Pharmaceutical Industries Ltd
  • Bausch Health Companies
  • Glenmark Pharmaceuticals
  • Aclaris Therapeutics, Inc.
図表

List of Tables

  • Table 1 Global Topical Drug Delivery Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Topical Drug Delivery Market Outlook, By Route of Administration (2020-2028) ($MN)
  • Table 3 Global Topical Drug Delivery Market Outlook, By Vaginal Drug Delivery (2020-2028) ($MN)
  • Table 4 Global Topical Drug Delivery Market Outlook, By Rectal Drug Delivery (2020-2028) ($MN)
  • Table 5 Global Topical Drug Delivery Market Outlook, By Ophthalmic Drug Delivery (2020-2028) ($MN)
  • Table 6 Global Topical Drug Delivery Market Outlook, By Nasal Drug Delivery (2020-2028) ($MN)
  • Table 7 Global Topical Drug Delivery Market Outlook, By Dermal Drug Delivery (Skin) (2020-2028) ($MN)
  • Table 8 Global Topical Drug Delivery Market Outlook, By Product (2020-2028) ($MN)
  • Table 9 Global Topical Drug Delivery Market Outlook, By Liquid Formulations (2020-2028) ($MN)
  • Table 10 Global Topical Drug Delivery Market Outlook, By Suspensions (2020-2028) ($MN)
  • Table 11 Global Topical Drug Delivery Market Outlook, By Solutions (2020-2028) ($MN)
  • Table 12 Global Topical Drug Delivery Market Outlook, By Solid Formulations (2020-2028) ($MN)
  • Table 13 Global Topical Drug Delivery Market Outlook, By Suppositories (2020-2028) ($MN)
  • Table 14 Global Topical Drug Delivery Market Outlook, By Powders (2020-2028) ($MN)
  • Table 15 Global Topical Drug Delivery Market Outlook, By Devices (Transdermal Drug Delivery) (2020-2028) ($MN)
  • Table 16 Global Topical Drug Delivery Market Outlook, By Transdermal Semi-solids (2020-2028) ($MN)
  • Table 17 Global Topical Drug Delivery Market Outlook, By Transdermal Patches (2020-2028) ($MN)
  • Table 18 Global Topical Drug Delivery Market Outlook, By Inhaler (2020-2028) ($MN)
  • Table 19 Global Topical Drug Delivery Market Outlook, By Semi-Solid Formulations (2020-2028) ($MN)
  • Table 20 Global Topical Drug Delivery Market Outlook, By Pastes (2020-2028) ($MN)
  • Table 21 Global Topical Drug Delivery Market Outlook, By Ointments (2020-2028) ($MN)
  • Table 22 Global Topical Drug Delivery Market Outlook, By Lotions (2020-2028) ($MN)
  • Table 23 Global Topical Drug Delivery Market Outlook, By Gels (2020-2028) ($MN)
  • Table 24 Global Topical Drug Delivery Market Outlook, By Creams (2020-2028) ($MN)
  • Table 25 Global Topical Drug Delivery Market Outlook, By Distribution Channel (2020-2028) ($MN)
  • Table 26 Global Topical Drug Delivery Market Outlook, By Retail (2020-2028) ($MN)
  • Table 27 Global Topical Drug Delivery Market Outlook, By Offline (2020-2028) ($MN)
  • Table 28 Global Topical Drug Delivery Market Outlook, By Online (2020-2028) ($MN)
  • Table 29 Global Topical Drug Delivery Market Outlook, By Direct Tenders (2020-2028) ($MN)
  • Table 30 Global Topical Drug Delivery Market Outlook, By Facility of Use (2020-2028) ($MN)
  • Table 31 Global Topical Drug Delivery Market Outlook, By Hospitals & Private Clinics (2020-2028) ($MN)
  • Table 32 Global Topical Drug Delivery Market Outlook, By Home Care Settings (2020-2028) ($MN)
  • Table 33 Global Topical Drug Delivery Market Outlook, By Burn Centers (2020-2028) ($MN)
  • Table 34 Global Topical Drug Delivery Market Outlook, By Other Facilities (2020-2028) ($MN)
  • Table 35 Global Topical Drug Delivery Market Outlook, By Academic & Research Institutes (2020-2028) ($MN)
  • Table 36 Global Topical Drug Delivery Market Outlook, By Diagnostic Centers (2020-2028) ($MN)
  • Table 37 Global Topical Drug Delivery Market Outlook, By Type (2020-2028) ($MN)
  • Table 38 Global Topical Drug Delivery Market Outlook, By Hard & Rigid Braces (2020-2028) ($MN)
  • Table 39 Global Topical Drug Delivery Market Outlook, By Hinged Braces (2020-2028) ($MN)
  • Table 40 Global Topical Drug Delivery Market Outlook, By Soft & Elastic Braces (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

目次
Product Code: SMRC21699

According to Stratistics MRC, the Global Topical Drug Delivery Market is accounted for $109.80 billion in 2022 and is expected to reach $178.15 billion by 2028 growing at a CAGR of 8.4% during the forecast period. Topical drug delivery refers to the delivery of drugs through topical routes such as the skin, mucosa, or cavities in the body. These are applied locally to avoid the first-pass effect of the drug or for site-specific action. A topical mode of delivery offers benefits such as site-specificity, eliminating fluctuations in the levels of drugs, improved suitability for self-medication, and better compliance.

The total global cell and gene drug delivery devices market was dominated by North America and Europe, which were responsible for than 83 percent of the market all together. It was forecast that this domination will continue until 2030, although the market share in the U.S. was projected to drop some four percent. It was estimated that 60 percent of drugs in the R&D pipeline were with an injectable delivery route, thus making it the top delivery route for drugs in pipeline.

Market Dynamics:

Driver:

Growing prevalence of skin diseases

Growing prevalence of skin disorders and infections including acne, psoriasis, and eczema, rising incidences of minor skin injuries such as skin burns, increasing self-medication practices, and increased consumer spending on dermatological products such as anti-acne and anti-septic creams and gels are among the other key factors expected to drive the global topical drug delivery market. As topical drug delivery is the first line of treatment for the majority of skin diseases, the demand for advanced topical products is expected to increase in the coming years.

Restraint:

Availability of alternative modes of drug delivery

There are several alternative drug delivery modes available for patients and end users. The benefits of these alternatives over topical drug delivery form a key restraint to the growth of this market. Of these, the oral route is the most preferred as it is easy to use, convenient, cost-effective, safe, and acceptable. Furthermore, orally administered drugs can be conveniently stored and are portable, economical, noninvasive, and safe.

Opportunity:

Delivery of biologics through the transdermal route

The delivery of biologics through the transdermal route is one of the emerging trends in the topical drug delivery market. The transdermal delivery of large molecules as an alternative to intramuscular, subcutaneous, or intravenous routes of administration is expected to provide significant patient benefits, such as painless drug delivery and cost-effective treatment.

Threat:

Technical barriers related to skin irritation

The chance for local adverse reactions and skin irritation is a significant challenge for topical drug delivery formulation and transdermal systems. However, the emergence of novel techniques for skin permeation and the development of methods to reduce skin irritation would help widen the topical drug delivery formulations and transdermal systems market for hydrophilic compounds, macromolecules, and conventional drugs for new therapeutic indications.

The home care settings segment is expected to be the largest during the forecast period

The home care settings segment is expected to be the largest during the forecast period owing to the convenience and affordability of topical drugs for home administration. Also, for patients requiring long-term therapy, inpatient care is not only extremely expensive but also prevents patients from resuming a normal lifestyle and work activities. In this regard, technological advancements have helped patients undergo therapies effectively and safely at home.

The dermal drug delivery (skin) segment is expected to have the highest CAGR during the forecast period

The dermal drug delivery segment is expected to witness the highest growth during the forecast period. This can be attributed to the advantages of dermal drug delivery over other topical drug delivery methods, such as convenience and greater patient compliance. Besides, dermal products have fewer regulatory requirements than ophthalmic products, where sterility testing is mandatory.

Region with largest share:

North America is projected to hold the largest market share owing to the growing product launches by various key players in the region. Due to the COVID-19 outbreak, the market is expecting to observe positive growth. This is mainly due to the novel treatment being developed. The growing burden of skin-related conditions is also expected to accelerate the market growth.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR due to the high incidence of skin diseases (such as skin cancer), increasing use of contraceptives, and the growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems.

Key players in the market

Some of the key players profiled in the Topical Drug Delivery Market include Teligent Pharma, Almirall, S.A, Perrigo Pharma, Novartis AG, Bayer AG, Mylan, Merck & Co, LEO Pharma , Johnson & Johnson, Agile Therapeutics Inc., Cipla Ltd, GlaxoSmithKline, Encore Dermatology, Inc., Crescita Therapeutics Inc., Taro Pharmaceutical Industries Ltd, Bausch Health Companies, Glenmark Pharmaceuticals, and Aclaris Therapeutics, Inc.

Key developments:

In February 2021: Almirall and MC2 Therapeutics went under an exclusive agreement for the commercialization of its product 'Wynzora', a topical drug indicated against the treatment of plaque psoriasis.

In December 2020: Agile Therapeutics Inc. introduced Twirla (levonorgestrel and ethinyl estradiol) transdermal system, which is a contraceptive patch.

In August 2020: LEO Pharma received United States Food and Drug Administration approval for its delgocitinib cream for the treatment of moderate-to-severe chronic hand eczema (CHE) in adults.

In November 2018: Bausch Healthcare expanded its manufacturing facility in Rochester in order to support and fulfill the demand of its topical eye health products.

Routes of Administration Covered:

  • Vaginal Drug Delivery
  • Rectal Drug Delivery
  • Ophthalmic Drug Delivery
  • Nasal Drug Delivery
  • Dermal Drug Delivery (Skin)

Products Covered:

  • Liquid Formulations
  • Solid Formulations
  • Devices (Transdermal Drug Delivery)
  • Semi-Solid Formulations

Distribution Channels Covered:

  • Retail
  • Direct Tenders

Facilities of Use Covered:

  • Hospitals & Private Clinics
  • Home Care Settings
  • Burn Centers
  • Other Facilities

Types Covered:

  • Hard & Rigid Braces
  • Hinged Braces
  • Soft & Elastic Braces

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Topical Drug Delivery Market, By Route of Administration

  • 5.1 Introduction
  • 5.2 Vaginal Drug Delivery
  • 5.3 Rectal Drug Delivery
  • 5.4 Ophthalmic Drug Delivery
  • 5.5 Nasal Drug Delivery
  • 5.6 Dermal Drug Delivery (Skin)

6 Global Topical Drug Delivery Market, By Product

  • 6.1 Introduction
  • 6.2 Liquid Formulations
    • 6.2.1 Suspensions
    • 6.2.2 Solutions
  • 6.3 Solid Formulations
    • 6.3.1 Suppositories
    • 6.3.2 Powders
  • 6.4 Devices (Transdermal Drug Delivery)
    • 6.4.1 Transdermal Semi-solids
    • 6.4.2 Transdermal Patches
    • 6.4.3 Inhaler
  • 6.5 Semi-Solid Formulations
    • 6.5.1 Pastes
    • 6.5.2 Ointments
    • 6.5.3 Lotions
    • 6.5.4 Gels
    • 6.5.5 Creams

7 Global Topical Drug Delivery Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Retail
    • 7.2.1 Offline
    • 7.2.2 Online
  • 7.3 Direct Tenders

8 Global Topical Drug Delivery Market, By Facility of Use

  • 8.1 Introduction
  • 8.2 Hospitals & Private Clinics
  • 8.3 Home Care Settings
  • 8.4 Burn Centers
  • 8.5 Other Facilities
    • 8.5.1 Academic & Research Institutes
    • 8.5.2 Diagnostic Centers

9 Global Topical Drug Delivery Market, By Type

  • 9.1 Introduction
  • 9.2 Hard & Rigid Braces
  • 9.3 Hinged Braces
  • 9.4 Soft & Elastic Braces

10 Global Topical Drug Delivery Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Teligent Pharma
  • 12.2 Almirall, S.A
  • 12.3 Perrigo Pharma
  • 12.4 Novartis AG
  • 12.5 Bayer AG
  • 12.6 Mylan
  • 12.7 Merck & Co
  • 12.8 LEO Pharma
  • 12.9 Johnson & Johnson
  • 12.10 Agile Therapeutics Inc.
  • 12.11 Cipla Ltd
  • 12.12 GlaxoSmithKline
  • 12.13 Encore Dermatology, Inc.
  • 12.14 Crescita Therapeutics Inc.
  • 12.15 Taro Pharmaceutical Industries Ltd
  • 12.16 Bausch Health Companies
  • 12.17 Glenmark Pharmaceuticals
  • 12.18 Aclaris Therapeutics, Inc.